Data from A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer

Autor: Judy E. Garber, F. Lennie Wong, Sandhya Pruthi, Linda Overholser, Sofia D. Merajver, Susan A. Melin, Larissa A. Korde, Melissa M. Hudson, David Hodgson, Tara Henderson, Anne Blaes, Therese B. Bevers, Saro H. Armenian, Kathryn W. Zamora, Caroline A. Reich, Heidi Umphrey, Kandice Smith, Wendy Landier, Yanjun Chen, Lindsey Hageman, Melanie R. Palomares, Smita Bhatia

Purpose:Low-dose tamoxifen reduces breast cancer risk, but remains untested in chest-irradiated cancer survivors—a population with breast cancer risk comparable with BRCA mutation carriers. We hypothesized that low-dose tamoxifen would be safe and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::612b1477ef4dc4596da160dcf2b58fbd
https://doi.org/10.1158/1078-0432.c.6530109.v1

Abstract P2-07-03: Refining neoadjuvant predictors of three year distant metastasis free survival: Integrating volume change as measured by MRI with residual cancer burden

Autor: Melissa Paoloni, A Magliocco, W Yang, AD Elias, Mark A. Rosen, H Sattar, AS Clark, Jane Perlmutter, Gillian L. Hirst, Sy Chui, KA Ward, Richard Schwab, Anne M. Wallace, B Chen, AM DeMichele, Michael D. Nelson, Michael Feldman, L.J. van 't Veer, Scott M. Berry, Y-Y Chen, Amy Wilson, Larissa A. Korde, Lajos Pusztai, Haydee Ojeda-Fournier, O Fadare, Brian Datnow, W K Bernreuter, PK Haugen, H Abe, Rebecca K. Viscusi, M. Melisko, K Oh, Molly Klein, W Li, Julia L. Clennell, C Yau, S. L. Moulder, G Krings, Judy C. Boughey, Rita Nanda, David M. Euhus, Heather Beckwith, Heidi Umphrey, S Wei, Nola M. Hylton, C Isaacs, Donald A. Berry, Ruby Singhrao, AJ Chien, William Fraser Symmans, Erica Stringer-Reasor, Erin D. Ellis, Qamar J. Khan, S Yang, O. I. Olopade, P Mhawech-Fauceglia, Meredith Buxton, Jeffrey B. Matthews, T Vinh, Hyo S. Han, Adam Asare, M Rendi, C Hatzis, Shelly S. Lo, Janice Lu, Donald W. Northfelt, Debu Tripathy, Pulin Sheth, DH Bang, Dulcy Wolverton, Bethany L. Niell, K Adamson, Ashish Sanil, HS Rugo, Kathy R. Brandt, S Sams, Je Lang, Mohammad Eghtedari, Teresa Helsten, S Sahoo, William C. Wood, Minetta C. Liu, Katherine Steeg, John W. Park, A Ferero-Torres, Erin P. Crane, J Zeck, Douglas Yee, A Adams, Ossama Tawfik, L Grasso LeBeau, Stefan E. Pambuccian, I Ocal, Kathleen Kemmer, KS Albain, Basak E. Dogan, Bonnie N. Joe, Kirsten K. Edmiston, LJ Esserman, Garry Peterson, S Asare, Shuko Harada

Publikováno v: Cancer Research. 79:P2-07

Background: Patients achieving a pathologic complete response (pCR) following neoadjuvant therapy have significantly improved event-free survival relative to those who do not; and pCR is an FDA-accepted endpoint to support accelerated approval of nov

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0a650c67d6e1172919fb7c74efc7490c
https://doi.org/10.1158/1538-7445.sabcs18-p2-07-03

Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL

Autor: Dae Hee Bang, Christina Yau, Stefanie Woodard, Bethany L. Niell, Marisa H. Borders, Savannah C. Partridge, Angela DeMichele, Michael A. Cohen, Jennifer S. Drukteinis, Bruce Porter, Elise Berman, W K Bernreuter, Fredrik Strand, Deepa Sheth, Linda Hovanessian-Larsen, Patrick J. Bolan, Despina Kontos, Vignesh A. Arasu, Michael D. Nelson, Nola M. Hylton, Elizabeth S. McDonald, Alex Anh-Tu Nguyen, Bonnie N. Joe, Natsuko Onishi, Theresa Kuritza, Neda Jafarian, Jessica Gibbs, Wei T. Yang, David C. Newitt, Wen Li, Kelly Fountain, Basak Dogan, Pulin Sheth, Dulcy Wolverton, Kathleen M. Ward, Erin P. Crane, An L Church, Thomas L. Chenevert, John Kornak, Lara A. Hardesty, Dan Lopez-Paniagua, Charlotte Dillis, Ella F. Jones, Lisa J. Wilmes, Karen Y. Oh, Mary S. Newell, Heidi Umphrey, Hiroyuki Abe, Donald A. Berry, Alina Tudorica, Mark A. Rosen, Laura J. Esserman, Marina E. Giurescu, Sally Goudreau, Mohammad Eghtedari, Haydee Ojeda-Fournier, Constance D. Lehman, Kathy R. Brandt, Kevin Morley, Kathryn W. Zamora, Kimberly A. Fitzpatrick, Elissa R. Price

Publikováno v: NPJ breast cancer, vol 6, iss 1
NPJ Breast Cancer

Dynamic contrast-enhanced (DCE) MRI provides both morphological and functional information regarding breast tumor response to neoadjuvant chemotherapy (NAC). The purpose of this retrospective study is to test if prediction models combining multiple M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c6a10e0b4b4db3adddb2b166f5834e
https://escholarship.org/uc/item/25w77044

Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial

Autor: Thomas L. Chenevert, Basak E. Dogan, Haydee Ojeda-Fournier, Karen Y. Oh, Bonnie N. Joe, Justin Romanoff, Nola M. Hylton, Savannah C. Partridge, Zheng Zhang, Laura J. Esserman, Helga S. Marques, Heidi Umphrey, Jessica Gibbs, Mark A. Rosen, Jennifer S. Drukteinis, Hiroyuki Abe, Lisa Cimino, Patrick J. Bolan, David C. Newitt

Publikováno v: Radiology. 289:618-627

Purpose To determine if the change in tumor apparent diffusion coefficient (ADC) at diffusion-weighted (DW) MRI is predictive of pathologic complete response (pCR) to neoadjuvant chemotherapy for breast cancer. Materials and Methods In this prospecti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dd411f1a6ee06ce9f58693d8ee72dfe8
https://doi.org/10.1148/radiol.2018180273

Contrast-Enhanced Spectral Mammography in Breast Imaging

Autor: Shannon Gulla, Jennifer F. De Los Santos, Heidi Umphrey, Rachael Lancaster

Publikováno v: Seminars in Roentgenology. 53:294-300

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d070f1490b72373d13d3eaa4f518d680
https://doi.org/10.1053/j.ro.2018.08.003